Kathryn Haskins

Affiliations: 
Molecular Biology University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Area:
Immunology, Molecular Biology, Cell Biology
Google:
"Kathryn Haskins"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wenzlau JM, Peterson OJ, Vomund AN, et al. (2024) Mapping of a hybrid insulin peptide in the inflamed islet β-cells from NOD mice. Frontiers in Immunology. 15: 1348131
Callebaut A, Guyer P, Baker RL, et al. (2024) An Insulin-Chromogranin A Hybrid Peptide activates DR11 restricted T cells in human type 1 diabetes. Diabetes
Wenzlau JM, Gu Y, Michels A, et al. (2023) Identification of Autoantibodies to a Hybrid Insulin Peptide in Type 1 Diabetes. Diagnostics (Basel, Switzerland). 13
Crawford SA, Wiles TA, Wenzlau JM, et al. (2022) Cathepsin D Drives the Formation of Hybrid Insulin Peptides Relevant to the Pathogenesis of Type 1 Diabetes. Diabetes
Wenzlau JM, DiLisio JE, Barbour G, et al. (2022) Insulin B-chain hybrid peptides are agonists for T cells reactive to insulin B:9-23 in autoimmune diabetes. Frontiers in Immunology. 13: 926650
Jamison BL, DiLisio JE, Beard KS, et al. (2022) Tolerogenic Delivery of a Hybrid Insulin Peptide Markedly Prolongs Islet Graft Survival in the Non-Obese Diabetic (NOD) Mouse. Diabetes
Neef T, Ifergan I, Beddow S, et al. (2021) Tolerance Induced by Antigen-Loaded PLG Nanoparticles Affects the Phenotype and Trafficking of Transgenic CD4 and CD8 T Cells. Cells. 10
Wiles TA, Hohenstein A, Landry LG, et al. (2021) Characterization of Human CD4 T Cells Specific for a C-Peptide/C-Peptide Hybrid Insulin Peptide. Frontiers in Immunology. 12: 668680
DiLisio JE, Haskins K. (2021) Induction of Antigen-Specific Tolerance in Autoimmune Diabetes with Nanoparticles Containing Hybrid Insulin Peptides. Biomedicines. 9
Haskins K, Wenzlau J. (2020) Cluster of Differentiation 4 T Cells and Neoantigens in Autoimmune Diabetes. Critical Reviews in Immunology. 40: 441-446
See more...